From: Media reporting of tenofovir trials in Cambodia and Cameroon
Study Location | Population Group | Sponsor | Study Goal | Expected Initial Results |
---|---|---|---|---|
Cambodia | Commercial sex workers 960 volunteers | NIH | Safety & efficacy | 2007 |
Cameroon, Ghana | High-risk women 800 volunteers | FHI | Safety & efficacy | 2007 |
Malawi | High-risk men 500 volunteers | FHI | Safety & efficacy | 2007 |
Botswana | Young adults 1,200 volunteers | CDC | Safety &efficacy | 2007 |
Thailand | Injection drug users 1,600 volunteers | CDC | Safety & efficacy | 2007 |
United States | Men who have sex with men | CDC | Safety | 2007 |
Peru | Men who have sex with men 2,100 volunteers | NIH | Safety & efficacy | 2008 |